Publications

This page is constantly being updated. Apologies for any inconvenience this may cause!

First author

Assessment of Symptom Network Density as a Prognostic Marker of Treatment Response in Adolescent Depression.
Schweren LJS, van Borkulo C, Fried EI, & Goodyer I.JAMA Psychiatry, November 2017 (in press)

Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition.
Schweren LJS, Hoekstra PJ, van Lieshout M, Rommelse NNJ, Franke B, Oosterlaan J, Buitelaar JK, Hartman CA. 2017, under revision

Memory performance and hippocampus structure after low-frequency recreational stimulant use in adolescents.
Schweren LJS, Giedd J, Castro N, Bartsch H, Squeglia LM, Meloy MJ, Tapert S. 2017, under revision
 

Stimulant treatment trajectories are associated with neural reward processing in attention-deficit/hyperactivity disorder.
Schweren LJS, Groenman AP, von Rhein D, Weeda W, Faraone SF, Luman M, van Ewijk H, Heslenfeld DJ, Franke B, Buitelaar JK, Oosterlaan J, Hoekstra PJ, Hartman CA. J Clin Psychiatry. 2017 Jul;78(7):e790-e796
 

Age and DRD4 genotype moderate associations between stimulant treatment history and cortex structure in ADHD. 
Schweren LJS, Hartman CA, Heslenfeld DJ, Groenman AP, Franke B, Oosterlaan J, Buitelaar JK, Hoekstra PJ. J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):877-85.

Also see this editorial by Samuel Cortese
 

Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder. 
Schweren LJS, Hartman CA, Zwiers MP, Heslenfeld DJ, Franke B, Oosterlaan J, Buitelaar JK, Hoekstra PJ. Eur Neuropsychopharmacol. 2016 Apr;26(4):674-83. PMID:26899587
 

Thinner medial temporal cortex in adolescents with attention-deficit/hyperactivity disorder and the effects of stimulants.
Schweren LJS, Hartman CA, Heslenfeld DJ, van der Meer D, Franke B, Oosterlaan J, Buitelaar JK, Faraone SV, Hoekstra PJ. J Am Acad Child Adolesc Psychiatry. 2015 Aug;54(8):660-7. PMID: 26210335

Also see this editorial by Philip Shaw
 

Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
Schweren LJS, Hartman CA, Zwiers MP, Heslenfeld DJ, van der Meer D, Franke B, Oosterlaan J, Buitelaar JK, Hoekstra PJ. Eur Child Adolesc Psychiatry. 2015 Aug;24(8):959-68. PMID: 25395383

Also see this blog about the article

 

MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
Schweren LJS, de Zeeuw P, Durston S. Eur Neuropsychopharmacol. 2013 Oct;23(10):1151-64. PMID: 23165220
 

Stimulantia en het zich ontwikkelende brein (invited review in Dutch).
Schweren LJS, Schrantee A.* PiL – Praktijkgerichte Nascholing over Farmacotherapie in de Eerste Lijn. 2017 Jun;7(2). *shared first author

ADHD, lange-termijn medicatiegebruik, en het zich ontwikkelende brein (invited review in Dutch).
Schweren LJS.Pharmaceutisch Weekblad, 2017 Apr

Co-author
 

Healthy cortical development through adolescence and early adulthood.
Forde JN, Ronan L, Zwiers M, Schweren LJS, Alexander-Bloch AF, Franke B, Faraone SV, Oosterlaan J, Heslenfeld DJ, Hartman CA, Buitelaar JK, Hoekstra PJ. Submitted
 

Subcortical brain volume differences between participants with ADHD and healthy individuals across the lifespan: an ENIGMA collaboration.
Hoogman M, Bralten J, Hibar, Mennes M, Zwiers M, Schweren LJS, et al. [The ENIGMA-ADHD working group] Submitted
 

Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU, Bralten J, Mennes M, O’Dwyer L, van Hulzen KJ, Rommelse N, Schweren LJS, Hoekstra PJ, Hartman CA, Heslenfeld D, Oosterlaan J, Faraone SV, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar JK. JAMA psychiatry. 2015 May;72(5):490-9. PMID:25785435
 

Brain correlates of the interaction between 5-HTTLPR and psychosocial stress mediating attention-deficit/hyperactivity disorder severity.
van der Meer D, Hoekstra PJ, Zwiers M, Mennes M, Schweren LJS, Franke B, Heslenfeld DJ, Oosterlaan J, Faraone SV, Buitelaar JK, Hartman CA.Am J Psychiatry. 2015 Aug 1;172(8):768-75. PMID: 25998280
 

Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder.
de Wit SJ, Alonso P, Schweren LJS, Mataix-Cols D, Lochner C, Menchón JM, Stein DJ, Fouche JP, Soriano-Mas C, Sato JR, Hoexter MQ, Denys D, Nakamae T, Nishida S, Kwon JS, Jang JH, Busatto GF, Cardoner N, Cath DC, Fukui K, Jung WH, Kim SN, Miguel EC, Narumoto J, Phillips ML, Pujol J, Remijnse PL, Sakai Y, Shin NY, Yamada K, Veltman DJ, van den Heuvel OA. Am J Psychiatry. 2014 Mar;171(3):340-9. PMID: 24220667
 

Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis.
Hulst HE, Schoonheim MM, Roosendaal SD, Popescu V, Schweren LJS, van der Werf YD, Visser LH, Polman CH, Barkhof F, Geurts JJ. Hum Brain Mapp. 2012 Oct;33(10):2268-80. PMID: 21898674
 

YICAP/ECAP international young investigators paper and grant writing workshop.
Mudra S, Völker U, Schweren LJS, Wessing I, Seitz J. Eur Child Adolesc Psychiatry. 2015 Feb;24(2):247-8. PMID: 25502870

Also see this blog about the 2016 ESCAP Research Academy in Madrid